Skip to content

Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study

Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06749145
Enrollment
410
Registered
2024-12-27
Start date
2025-09-16
Completion date
2028-08-31
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis

Keywords

aortic stenosis, artificial intelligence

Brief summary

The DETECT-AS Diagnostic Study will assess the performance of artificial intelligence (AI) risk predictions to detect aortic stenosis using results from portable electrocardiogram (ECG) and cardiac ultrasound devices.

Interventions

DIAGNOSTIC_TESTPortable 1-lead electrocardiogram

Portable 1-lead electrocardiogram (ECG) performed with the FDA-approved AliveCor KardiaMobile device.

DIAGNOSTIC_TESTPoint-of-care ultrasound

Point-of-care ultrasound performed with the FDA-approved VScan Air device.

OTHERAI-ECG risk algorithm

Artificial intelligence (AI) risk algorithm for aortic stenosis using a 1-lead electrocardiogram

OTHERAI-POCUS

Artificial intelligence (AI) risk algorithm for aortic stenosis using cardiac ultrasound plax videos.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Icahn School of Medicine at Mount Sinai
CollaboratorOTHER
The Methodist Hospital Research Institute
CollaboratorOTHER
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 70 years or older * Attending a routine outpatient primary care clinic at one of the three enrollment sites

Exclusion criteria

* Opted out of research studies * Non-English speaking * Urgent or emergent visits, defined as a visit for an illness or injury that needs attention quickly or is life-threatening * Any echocardiogram within 12 months of clinic visit * Prior history of moderate or severe AS * Prior history of aortic valve replacement or repair, including transcatheter and surgical AVR with either a bioprosthetic or mechanical valve * Presence of implantable cardiac devices, including permanent cardiac pacer, implantable cardioverter-defibrillator, or left ventricular assist device * Prior heart transplant * History of dementia * Documented life expectancy of \<1 year or current participation in hospice services.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants diagnosed with advanced aortic stenosis (AS) by transthoracic echocardiogram (TTE)Until 12 months from the baseline visitThe number of participants diagnosed with advanced AS by TTE at 12 months. Diagnosis of advanced AS is defined as diagnosis of moderate or severe AS as documented in the participant's electronic health record (EHR) at 12 months and adjudication of outcome via review of echocardiographic reports and videos performed by blinded members of the echocardiographic lab at the coordinating center.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026